SCAFFIDI RUNCHELLA, LIVIO
 Distribuzione geografica
Continente #
NA - Nord America 121
AS - Asia 64
EU - Europa 40
AF - Africa 5
SA - Sud America 2
Totale 232
Nazione #
US - Stati Uniti d'America 119
SG - Singapore 28
IT - Italia 16
CN - Cina 12
DE - Germania 11
HK - Hong Kong 8
IN - India 7
VN - Vietnam 5
MA - Marocco 4
GB - Regno Unito 3
SE - Svezia 3
FI - Finlandia 2
FR - Francia 2
AR - Argentina 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
MX - Messico 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 232
Città #
Ashburn 18
Fairfield 15
Singapore 12
San Jose 9
Hong Kong 8
Woodbridge 8
Genova 6
Munich 6
Seattle 6
Wilmington 5
Beijing 3
Chandler 3
Frankfurt am Main 3
Houston 3
Lanciano 3
Rome 3
Santa Clara 3
The Dalles 3
Bühl 2
Cambridge 2
Casablanca 2
Cosenza 2
Genoa 2
Ho Chi Minh City 2
Lauterbourg 2
Millbury 2
Plano 2
Princeton 2
Redondo Beach 2
Ann Arbor 1
Astana 1
Basra 1
Bayonne 1
Boardman 1
Brussels 1
Can Tho 1
Columbus 1
Córdoba 1
Dallas 1
Helsinki 1
Jiaxing 1
Lahore 1
Lincolnton 1
London 1
Nanjing 1
New Delhi 1
Olomouc 1
Phenix City 1
Poplar 1
Port Talbot 1
Quảng Ngãi 1
Rabat 1
San Antonio 1
San Francisco 1
Shenzhen 1
Tangier 1
Taubaté 1
Tokyo 1
Turku 1
Ukiah 1
Totale 170
Nome #
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 78
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 76
null 54
null 42
Totale 250
Categoria #
all - tutte 625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/202227 0 0 1 2 2 1 3 3 2 2 8 3
2022/202317 3 0 0 0 3 0 0 2 5 0 4 0
2023/202415 0 1 0 3 2 0 2 0 0 3 4 0
2024/202550 0 0 5 1 4 1 3 0 10 2 6 18
2025/202675 19 0 4 4 11 3 9 2 9 11 3 0
Totale 250